Literature DB >> 27003897

Control of hair growth using long-pulsed alexandrite laser is an efficient and cost effective therapy for patients suffering from recurrent pilonidal disease.

Muhammad Adil Abbas Khan1, Ammar Asrar Javed2, Karthikeyan Srinivasan Govindan3, Sadia Rafiq3, Kay Thomas3, Lynne Baker3, John Kenealy3.   

Abstract

Pilonidal sinus (PNS) and its surgical management have a profound impact on hospital resources in terms of finances and productive man-hours. Surgical treatment has been the mainstay of treatment of both acute and chronic pilonidal sinus but recurrence is common. The control of hair growth in the sinus region plays an important role in preventing recurrence. Here, we discuss our experience of treating 19 patients suffering from recurrent pilonidal sinus with laser depilation and its long-term cost effectiveness. This is a retrospective study on patients who had recurrence of pilonidal sinus following multiple surgical treatments. They were treated using long-pulsed alexandrite laser for depilation in the sinus area, an outpatient procedure. Their clinical characteristics and outcomes were then evaluated. There was a significant reduction in hair density after laser treatment (p < 0.001). The disease-free period after laser treatment was significantly longer than that one after surgical treatment (p < 0.001). The average cost of repeated surgical treatment per disease-free month was significantly higher than that of laser treatment (p < 0.001). Evidence suggests the role of natal cleft hair growth in the evolution of the pilonidal disease; therefore, control of hair growth should be considered as an adjunct to the initial treatment via surgery. Compared to surgical treatment of recurrences, laser depilation is an efficient and cost-effective method of preventing recurrence and reducing morbidity and loss of man-hours. We suggest that laser depilation of the pilonidal sinus should be funded by clinical commissioning groups.

Entities:  

Keywords:  Cost reduction; Laser depilation; Laser treatment; Pilonidal sinus; Recurrent pilonidal sinus

Mesh:

Substances:

Year:  2016        PMID: 27003897     DOI: 10.1007/s10103-016-1920-0

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  26 in total

Review 1.  Laser hair removal.

Authors:  Omar A Ibrahimi; Mathew M Avram; C William Hanke; Suzanne L Kilmer; R Rox Anderson
Journal:  Dermatol Ther       Date:  2011 Jan-Feb       Impact factor: 2.851

2.  Laser hair removal.

Authors:  Richard J Ort; Christine Dierickx
Journal:  Semin Cutan Med Surg       Date:  2002-06

Review 3.  Lasers and light sources for the removal of unwanted hair.

Authors:  Michael H Gold
Journal:  Clin Dermatol       Date:  2007 Sep-Oct       Impact factor: 3.541

4.  Successful treatment of recurrent pilonidal sinus with laser epilation.

Authors:  Nerea Landa; Oscar Aller; Nagore Landa-Gundin; Jaione Torrontegui; Jose L Azpiazu
Journal:  Dermatol Surg       Date:  2005-06       Impact factor: 3.398

5.  Ruby laser hair removal: evaluation of long-term efficacy and side effects.

Authors:  V B Campos; C C Dierickx; W A Farinelli; T Y Lin; W Manuskiatti; R R Anderson
Journal:  Lasers Surg Med       Date:  2000       Impact factor: 4.025

6.  Pilonidal sinus: management objectives.

Authors:  F O Stephens; R B Stephens
Journal:  Aust N Z J Surg       Date:  1995-08

7.  Pilonidal disease: origin from follicles of hairs and results of follicle removal as treatment.

Authors:  J Bascom
Journal:  Surgery       Date:  1980-05       Impact factor: 3.982

8.  Alexandrite laser hair removal is safe for Fitzpatrick skin types IV-VI.

Authors:  C Garcia; H Alamoudi; M Nakib; S Zimmo
Journal:  Dermatol Surg       Date:  2000-02       Impact factor: 3.398

9.  Laser depilation of the natal cleft--an aid to healing the pilonidal sinus.

Authors:  Joy Odili; David Gault
Journal:  Ann R Coll Surg Engl       Date:  2002-01       Impact factor: 1.891

10.  Evaluation of 60 patients with pilonidal sinus treated with laser epilation after surgery.

Authors:  Yasemin Oram; Ferayi Kahraman; Yelda Karincaoğlu; Erkan Koyuncu
Journal:  Dermatol Surg       Date:  2009-12-04       Impact factor: 3.398

View more
  7 in total

1.  Removal of unwanted hair: efficacy, tolerability, and safety of long-pulsed 755-nm alexandrite laser equipped with a sapphire handpiece.

Authors:  Steven Paul Nistico; Ester Del Duca; Francesca Farnetani; Stefania Guida; Giovanni Pellacani; Ali Rajabi-Estarabadi; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2018-04-13       Impact factor: 3.161

Review 2.  The effect of hair removal after surgery for sacrococcygeal pilonidal sinus disease: a systematic review of the literature.

Authors:  A A Pronk; L Eppink; N Smakman; E J B Furnee
Journal:  Tech Coloproctol       Date:  2017-11-28       Impact factor: 3.781

3.  The SiLaC procedure for pilonidal sinus disease: long-term outcomes of a single institution prospective study.

Authors:  M Dessily; M Dziubeck; E Chahidi; V Simonelli
Journal:  Tech Coloproctol       Date:  2019-11-26       Impact factor: 3.781

4.  Is conservative treatment an effective option for pilonidal sinus disease in children?

Authors:  Muazez Cevik; Mustafa Erman Dorterler; Latif Abbasoglu
Journal:  Int Wound J       Date:  2018-06-27       Impact factor: 3.315

5.  Laser may reduce recurrence rate in pilonidal sinus disease by reducing captured occipital hair.

Authors:  Dietrich Doll; Markus M Luedi
Journal:  Lasers Med Sci       Date:  2016-08-22       Impact factor: 3.161

6.  Outcomes and cost of medical and surgical treatments of pilonidal disease: A single institution's 10-year review.

Authors:  Kevin C Janek; Meaghan Kenfield; Lisa M Arkin; Lily Stalter; Giancarlo Tabaro; Charles M Leys; Hau D Le
Journal:  Surg Open Sci       Date:  2022-04-20

7.  Laser hair depilation for the prevention of disease recurrence in adolescents and young adults with pilonidal disease: study protocol for a randomized controlled trial.

Authors:  Peter C Minneci; Devin R Halleran; Amy E Lawrence; Beth A Fischer; Jennifer N Cooper; Katherine J Deans
Journal:  Trials       Date:  2018-11-01       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.